A PHASE I TRIAL OF RECOMBINANT VACCINIA VIRUS THAT EXPRESSES PSA IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Prostate cancer vaccine (Primary) ; Sargramostim
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2013 Biomarkers information updated
- 07 Aug 2006 Status changed from in progress to completed.
- 30 Sep 2005 New trial record.